- CytoDyn made changes to the CEO position and the company's board of directors. The company appears to have secured finances to keep the lights on for the time being.
- The company has gone into complete silence, which is a stark contrast to the company's previous practices. Investors are waiting for updates on several key items.
- The lack of communication has crushed the share price and has many investors wondering what is next for the company… and their investment. I propose a few scenarios.
- I discuss some potential scenarios and how I plan to manage my position while we wait for the company's next move.
For further details see:
CytoDyn: Holding Onto The Ruins From An End Of An Era